MF59-adjuvanted A/Astrakhan influenza vaccine induces cross-neutralizing H5N1 antibodies in ferrets against circulating clade 2.3.4.4b viruses. [PDF]
Segovia K +12 more
europepmc +1 more source
Investigating factors driving shifts in subtype dominance within H5Nx clade 2.3.4.4b high pathogenicity avian influenza viruses. [PDF]
Billington E +19 more
europepmc +1 more source
Assessment of influenza virus and coronavirus tropism, replication competence and disease severity in <i>ex vivo</i> and <i>in vitro</i> cultures of the human respiratory tract. [PDF]
Kuok DIT +11 more
europepmc +1 more source
Pan-continental spillover risk: integrated spatiotemporal, transmissibility and surveillance analysis of avian influenza a(H5N1) in Africa. [PDF]
Diaby M +15 more
europepmc +1 more source
Review of avian influenza outbreaks in Nigeria 2006-2025. [PDF]
Akanbi OB, Lakes T.
europepmc +1 more source
A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults. [PDF]
Cosgrove CA +6 more
europepmc +1 more source
Molecular surveillance and predictive risk modelling of avian influenza virus in wild birds in Egypt. [PDF]
Nabil NM +5 more
europepmc +1 more source
Temporal Dynamics and Surveillance of Highly Pathogenic H5 Avian Influenza in Wild Birds in Northern Serbia (2016-2025). [PDF]
Djurdjević B +6 more
europepmc +1 more source
Comparison of the adjuvant effect of AS01, AS03 and alum on the immune response to GMP-grade H5N1 antigen in guinea pigs. [PDF]
Eckhardt E +7 more
europepmc +1 more source
Epidemiology, Virology, and Control of Highly Pathogenic Avian Influenza in Kazakhstan. [PDF]
Bekshin Z +8 more
europepmc +1 more source

